{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T22:59:29Z","timestamp":1793228369561,"version":"4.5.0"},"reference-count":125,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Complement Altern Med"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s12906-016-1048-6","type":"journal-article","created":{"date-parts":[[2016,2,24]],"date-time":"2016-02-24T09:12:30Z","timestamp":1456305150000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":55,"title":["Passiflora incarnata attenuation of neuropathic allodynia and vulvodynia apropos GABA-ergic and opioidergic antinociceptive and behavioural mechanisms"],"prefix":"10.1186","volume":"16","author":[{"given":"Urooj","family":"Aman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1976-8314","authenticated-orcid":false,"given":"Fazal","family":"Subhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad","family":"Shahid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shehla","family":"Akbar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nisar","family":"Ahmad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gowhar","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khwaja","family":"Fawad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert D. E.","family":"Sewell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,2,24]]},"reference":[{"key":"1048_CR1","first-page":"210","volume-title":"Task Force on Taxonomy of the International Association for the Study of Pain. Classification of chronic pain: descriptions of chronic pain syndromes and definition of pain terms","author":"H Merskey","year":"1994","unstructured":"Merskey H, Bogduk N. Task Force on Taxonomy of the International Association for the Study of Pain. Classification of chronic pain: descriptions of chronic pain syndromes and definition of pain terms. 2nd ed. Seattle: IASP Press; 1994. p. 210\u20133.","edition":"2"},{"issue":"9168","key":"1048_CR2","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1016\/S0140-6736(99)01307-0","volume":"353","author":"CJ Woolf","year":"1999","unstructured":"Woolf CJ, Mannion RJ. Neuropathic pain: aetiology, symptoms, mechanisms, and management. Lancet. 1999;353(9168):1959\u201364.","journal-title":"Lancet"},{"issue":"11","key":"1048_CR3","doi-asserted-by":"crossref","first-page":"3760","DOI":"10.1172\/JCI42843","volume":"120","author":"AE Dubin","year":"2010","unstructured":"Dubin AE, Patapoutian A. Nociceptors: the sensors of the pain pathway. J Clin Invest. 2010;120(11):3760\u201372.","journal-title":"J Clin Invest"},{"issue":"9","key":"1048_CR4","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/S1474-4422(14)70102-4","volume":"13","author":"TS Jensen","year":"2014","unstructured":"Jensen TS, Finnerup NB. Allodynia and hyperalgesia in neuropathic pain: clinical manifestations and mechanisms. Lancet Neurol. 2014;13(9):924\u201335.","journal-title":"Lancet Neurol"},{"issue":"2","key":"1048_CR5","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/ncpneuro0113","volume":"2","author":"R Baron","year":"2006","unstructured":"Baron R. Mechanisms of disease: neuropathic pain\u2014a clinical perspective. Nat Clin Pract Neurol. 2006;2(2):95\u2013106.","journal-title":"Nat Clin Pract Neurol"},{"issue":"2","key":"1048_CR6","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.neulet.2004.08.043","volume":"370","author":"S Tatsumi","year":"2004","unstructured":"Tatsumi S, Mabuchi T, Abe T, Xu L, Minami T, Ito S. Analgesic effect of extracts of Chinese medicinal herbs Moutan cortex and Coicis semen on neuropathic pain in mice. Neurosci Lett. 2004;370(2):130\u20134.","journal-title":"Neurosci Lett"},{"issue":"2","key":"1048_CR7","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0014-2999(02)02428-7","volume":"453","author":"LB Bortalanza","year":"2002","unstructured":"Bortalanza LB, Ferreira J, Hess SC, Delle Monache F, Yunes RA, Calixto JB. Anti-allodynic action of the tormentic acid, a triterpene isolated from plant, against neuropathic and inflammatory persistent pain in mice. Eur J Pharmacol. 2002;453(2):203\u20138.","journal-title":"Eur J Pharmacol"},{"issue":"2","key":"1048_CR8","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.ejphar.2003.08.079","volume":"478","author":"CA Kassuya","year":"2003","unstructured":"Kassuya CA, Silvestre AA, Rehder VLG, Calixto JB. Anti-allodynic and anti-oedematogenic properties of the extract and lignans from Phyllanthus amarus in models of persistent inflammatory and neuropathic pain. Eur J Pharmacol. 2003;478(2):145\u201353.","journal-title":"Eur J Pharmacol"},{"issue":"3","key":"1048_CR9","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1097\/00002508-199709000-00011","volume":"13","author":"JM Rosenberg","year":"1997","unstructured":"Rosenberg JM, Harrell C, Ristic H, Werner RA, de Rosayro AM. The effect of gabapentin on neuropathic pain. Clin J Pain. 1997;13(3):251\u20135.","journal-title":"Clin J Pain"},{"issue":"13","key":"1048_CR10","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1056\/NEJMoa042580","volume":"352","author":"I Gilron","year":"2005","unstructured":"Gilron I, Bailey JM, Tu D, Holden RR, Weaver DF, Houlden RL. Morphine, gabapentin, or their combination for neuropathic pain. N Engl J Med. 2005;352(13):1324\u201334.","journal-title":"N Engl J Med"},{"issue":"6","key":"1048_CR11","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1097\/00002508-200211000-00001","volume":"18","author":"RH Dworkin","year":"2002","unstructured":"Dworkin RH. An overview of neuropathic pain: syndromes, symptoms, signs, and several mechanisms. Clin J Pain. 2002;18(6):343\u20139.","journal-title":"Clin J Pain"},{"issue":"1","key":"1048_CR12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jep.2004.02.023","volume":"94","author":"K Dhawan","year":"2004","unstructured":"Dhawan K, Dhawan S, Sharma A. Passiflora: a review update. J Ethnopharmacol. 2004;94(1):1\u201323.","journal-title":"J Ethnopharmacol"},{"issue":"5","key":"1048_CR13","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1055\/s-2003-39699","volume":"69","author":"E Marchart","year":"2003","unstructured":"Marchart E, Krenn L, Kopp B. Quantification of the flavonoid glycosides in Passiflora incarnata by capillary electrophoresis. Planta Med. 2003;69(5):452\u20136.","journal-title":"Planta Med"},{"issue":"3","key":"1048_CR14","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/j.jep.2013.09.047","volume":"150","author":"M Miroddi","year":"2013","unstructured":"Miroddi M, Calapai G, Navarra M, Minciullo PL, Gangemi S. Passiflora incarnata L.: Ethnopharmacology, clinical application, safety and evaluation of clinical trials. J Ethnopharmacol. 2013;150(3):791\u2013804.","journal-title":"J Ethnopharmacol"},{"key":"1048_CR15","first-page":"13","volume":"27","author":"A Menghini","year":"1993","unstructured":"Menghini A, Capuccella M, Mercati V, Mancini L, Buratta M. Flavonoid contents in Passiflora spp. Pharmacol Res. 1993;27:13\u20134.","journal-title":"Pharmacol Res"},{"issue":"6","key":"1048_CR16","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1055\/s-2006-962525","volume":"54","author":"E Speroni","year":"1988","unstructured":"Speroni E, Minghetti A. Neuropharmacological activity of extracts from Passiflora incarnata. Planta Med. 1988;54(6):488.","journal-title":"Planta Med"},{"issue":"1","key":"1048_CR17","first-page":"63","volume":"64","author":"O Grundmann","year":"2009","unstructured":"Grundmann O, W\u00e4hling C, Staiger C, Butterweck V. Anxiolytic effects of a passion flower (Passiflora incarnata L.) extract in the elevated plus maze in mice. Pharmazie. 2009;64(1):63\u20134.","journal-title":"Pharmazie"},{"issue":"1","key":"1048_CR18","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0378-8741(97)00042-1","volume":"57","author":"R Soulimani","year":"1997","unstructured":"Soulimani R, Younos C, Jarmouni S, Bousta D, Misslin R, Mortier F. Behavioural effects of Passiflora incarnata L. and its indole alkaloid and flavonoid derivatives and maltol in the mouse. J Ethnopharmacol. 1997;57(1):11\u201320.","journal-title":"J Ethnopharmacol"},{"issue":"2","key":"1048_CR19","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0378-8741(01)00339-7","volume":"78","author":"K Dhawan","year":"2001","unstructured":"Dhawan K, Kumar S, Sharma A. Anti-anxiety studies on extracts of Passiflora incarnata Linneaus. J Ethnopharmacol. 2001;78(2):165\u201370.","journal-title":"J Ethnopharmacol"},{"issue":"8","key":"1048_CR20","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1016\/S0367-326X(01)00322-7","volume":"72","author":"K Dhawan","year":"2001","unstructured":"Dhawan K, Kumar S, Sharma A. Anxiolytic activity of aerial and underground parts of Passiflora incarnata. Fitoterapia. 2001;72(8):922\u20136.","journal-title":"Fitoterapia"},{"issue":"1","key":"1048_CR21","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/1472-6882-7-26","volume":"7","author":"M Nassiri-Asl","year":"2007","unstructured":"Nassiri-Asl M, Shariati-Rad S, Zamansoltani F. Anticonvulsant effects of aerial parts of Passiflora incarnata extract in mice: involvement of benzodiazepine and opioid receptors. BMC Complement Altern Med. 2007;7(1):26.","journal-title":"BMC Complement Altern Med"},{"issue":"5","key":"1048_CR22","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S0367-326X(02)00116-8","volume":"73","author":"K Dhawan","year":"2002","unstructured":"Dhawan K, Sharma A. Antitussive activity of the methanol extract of Passiflora incarnata leaves. Fitoterapia. 2002;73(5):397\u20139.","journal-title":"Fitoterapia"},{"issue":"4","key":"1048_CR23","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1002\/ptr.1124","volume":"17","author":"K Dhawan","year":"2003","unstructured":"Dhawan K, Kumar S, Sharma A. Aphrodisiac activity of methanol extract of leaves of Passiflora incarnata Linn. in mice. Phytother Res. 2003;17(4):401\u20133.","journal-title":"Phytother Res"},{"issue":"7","key":"1048_CR24","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1002\/ptr.1151","volume":"17","author":"K Dhawan","year":"2003","unstructured":"Dhawan K, Kumar S, Sharma A. Antiasthmatic activity of the methanol extract of leaves of Passiflora incarnata. Phytother Res. 2003;17(7):821\u20132.","journal-title":"Phytother Res"},{"issue":"3","key":"1048_CR25","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.jep.2011.12.021","volume":"139","author":"RK Gupta","year":"2012","unstructured":"Gupta RK, Kumar D, Chaudhary AK, Maithani M, Singh R. Antidiabetic activity of Passiflora incarnata Linn. in streptozotocin-induced diabetes in mice. J Ethnopharmacol. 2012;139(3):801\u20136.","journal-title":"J Ethnopharmacol"},{"issue":"6","key":"1048_CR26","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1211\/0022357021779069","volume":"54","author":"K Dhawan","year":"2002","unstructured":"Dhawan K, Kumar S, Sharma A. Reversal of cannabinoids (\u03949-THC) by the benzoflavone moiety from methanol extract of Passiflora incarnata Linneaus in mice: a possible therapy for cannabinoid addiction. J Pharm Pharmacol. 2002;54(6):875\u201381.","journal-title":"J Pharm Pharmacol"},{"issue":"8","key":"1048_CR27","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1076\/phbi.40.8.576.14660","volume":"40","author":"K Dhawan","year":"2002","unstructured":"Dhawan K, Kumar S, Sharma A. Reversal of morphine tolerance and dependence by Passiflora incarnata-A traditional medicine to combat morphine addiction. Pharm Biol. 2002;40(8):576\u201380.","journal-title":"Pharm Biol"},{"issue":"4","key":"1048_CR28","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1080\/1355621021000006044","volume":"7","author":"K Dhawan","year":"2002","unstructured":"Dhawan K, Kumar S, Sharma A. Nicotine reversal effects of the benzoflavone moiety from Passiflora incarnata Linneaus in mice. Addict Biol. 2002;7(4):435\u201341.","journal-title":"Addict Biol"},{"issue":"4","key":"1048_CR29","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1080\/13556210310001646385","volume":"8","author":"K Dhawan","year":"2003","unstructured":"Dhawan K. Drug\/substance reversal effects of a novel tri-substituted benzoflavone moiety (BZF) isolated from Passiflora incarnata Linn.\u2013a brief perspective. Addict Biol. 2003;8(4):379\u201386.","journal-title":"Addict Biol"},{"issue":"4","key":"1048_CR30","doi-asserted-by":"crossref","first-page":"277","DOI":"10.4103\/0973-8258.59731","volume":"3","author":"S Patel","year":"2009","unstructured":"Patel S, Mohamed Saleem T, Ravi V, Shrestha B, Verma N, Gauthaman K. Passiflora incarnata Linn: a phytopharmacological review. Int J Green Pharm. 2009;3(4):277.","journal-title":"Int J Green Pharm"},{"issue":"1","key":"1048_CR31","doi-asserted-by":"crossref","first-page":"36","DOI":"10.4103\/0973-8258.97121","volume":"6","author":"S Ingale","year":"2012","unstructured":"Ingale S, Kasture S. Evaluation of analgesic activity of the leaves of Passiflora incarnata Linn. Int J Green Pharm. 2012;6(1):36.","journal-title":"Int J Green Pharm"},{"issue":"5","key":"1048_CR32","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1046\/j.1365-2710.2001.00367.x","volume":"26","author":"S Akhondzadeh","year":"2001","unstructured":"Akhondzadeh S, Naghavi H, Vazirian M, Shayeganpour A, Rashidi H, Khani M. Passionflower in the treatment of generalized anxiety: a pilot double-blind randomized controlled trial with oxazepam. J Clin Pharm Ther. 2001;26(5):363\u20137.","journal-title":"J Clin Pharm Ther"},{"issue":"6","key":"1048_CR33","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1213\/ane.0b013e318172c3f9","volume":"106","author":"A Movafegh","year":"2008","unstructured":"Movafegh A, Alizadeh R, Hajimohamadi F, Esfehani F, Nejatfar M. Preoperative oral Passiflora incarnata reduces anxiety in ambulatory surgery patients: a double-blind, placebo-controlled study. Anesth Analg. 2008;106(6):1728\u201332.","journal-title":"Anesth Analg"},{"issue":"6","key":"1048_CR34","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/S0944-7113(98)80041-X","volume":"5","author":"H Schulz","year":"1998","unstructured":"Schulz H, Jobert M, Hubner W. The quantitative EEG as a screening instrument to identify sedative effects of single doses of plant extracts in comparison with diazepam. Phytomedicine. 1998;5(6):449\u201358.","journal-title":"Phytomedicine"},{"issue":"5","key":"1048_CR35","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1046\/j.1365-2710.2001.00366.x","volume":"26","author":"S Akhondzadeh","year":"2001","unstructured":"Akhondzadeh S, Kashani L, Mobaseri M, Hosseini S, Nikzad S, Khani M. Passionflower in the treatment of opiates withdrawal: a double-blind randomized controlled trial. J Clin Pharm Ther. 2001;26(5):369\u201373.","journal-title":"J Clin Pharm Ther"},{"issue":"4","key":"1048_CR36","first-page":"609","volume":"2","author":"S Akhondzadeh","year":"2005","unstructured":"Akhondzadeh S, Mohammadi M, Momeni F. Passiflora incarnata in the treatment of attention-deficit hyperactivity disorder in children and adolescents. Future Medicine. 2005;2(4):609\u201314.","journal-title":"Future Medicine"},{"issue":"4","key":"1048_CR37","first-page":"202","volume":"15","author":"F Fahami","year":"2010","unstructured":"Fahami F, Asali Z, Aslani A, Fathizadeh N. A comparative study on the effects of Hypericum perforatum and Passion flower on the menopausal symptoms of women referring to Isfahan city health care centers. Iran J Nurs Midwifery Res. 2010;15(4):202\u20137.","journal-title":"Iran J Nurs Midwifery Res"},{"issue":"1\u20133","key":"1048_CR38","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0014-2999(01)01303-6","volume":"429","author":"M Zimmermann","year":"2001","unstructured":"Zimmermann M. Pathobiology of neuropathic pain. Eur J Pharmacol. 2001;429(1\u20133):23\u201337.","journal-title":"Eur J Pharmacol"},{"issue":"1, Peripheral N","key":"1048_CR39","first-page":"161","volume":"18","author":"N Attal","year":"2012","unstructured":"Attal N. Neuropathic pain: mechanisms, therapeutic approach, and interpretation of clinical trials. Continuum. 2012;18(1, Peripheral Neuropathy):161\u201375.","journal-title":"Continuum"},{"issue":"3, Supplement","key":"1048_CR40","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.4065\/mcp.2009.0649","volume":"85","author":"RH Dworkin","year":"2010","unstructured":"Dworkin RH, O\u2019Connor AB, Audette J, Baron R, Gourlay GK, Haanp\u00e4\u00e4 ML, et al. Recommendations for the pharmacological management of neuropathic pain: an overview and literature update. Mayo Clin Proc. 2010;85(3, Supplement):S3\u201314.","journal-title":"Mayo Clin Proc"},{"issue":"13","key":"1048_CR41","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1056\/NEJMcp022282","volume":"348","author":"JR Mendell","year":"2003","unstructured":"Mendell JR, Sahenk Z. Painful sensory neuropathy. N Engl J Med. 2003;348(13):1243\u201355.","journal-title":"N Engl J Med"},{"issue":"1","key":"1048_CR42","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.jns.2003.10.013","volume":"218","author":"B Brunelli","year":"2004","unstructured":"Brunelli B, Gorson KC. The use of complementary and alternative medicines by patients with peripheral neuropathy. J Neurol Sci. 2004;218(1):59\u201366.","journal-title":"J Neurol Sci"},{"issue":"10","key":"1048_CR43","doi-asserted-by":"crossref","first-page":"2557","DOI":"10.1016\/j.fct.2011.06.069","volume":"49","author":"A Muthuraman","year":"2011","unstructured":"Muthuraman A, Singh N, Jaggi AS. Protective effect of Acorus calamus L. in rat model of vincristine induced painful neuropathy: an evidence of anti-inflammatory and anti-oxidative activity. Food Chem Toxicol. 2011;49(10):2557\u201363.","journal-title":"Food Chem Toxicol"},{"issue":"1","key":"1048_CR44","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.jep.2011.04.038","volume":"136","author":"A Kaeidi","year":"2011","unstructured":"Kaeidi A, Esmaeili-Mahani S, Sheibani V, Abbasnejad M, Rasoulian B, Hajializadeh Z, et al. Olive (Olea europaea L.) leaf extract attenuates early diabetic neuropathic pain through prevention of high glucose-induced apoptosis: In vitro and in vivo studies. J Ethnopharmacol. 2011;136(1):188\u201396.","journal-title":"J Ethnopharmacol"},{"issue":"1","key":"1048_CR45","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/1472-6882-11-24","volume":"11","author":"A Muthuraman","year":"2011","unstructured":"Muthuraman A, Singh N. Attenuating effect of Acorus calamus extract in chronic constriction injury induced neuropathic pain in rats: an evidence of anti-oxidative, anti-inflammatory, neuroprotective and calcium inhibitory effects. BMC Complement Altern Med. 2011;11(1):24.","journal-title":"BMC Complement Altern Med"},{"issue":"8","key":"1048_CR46","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1007\/s11655-012-1188-6","volume":"18","author":"G Garg","year":"2012","unstructured":"Garg G, Adams JD. Treatment of neuropathic pain with plant medicines. Chin J Integr Med. 2012;18(8):565\u201370.","journal-title":"Chin J Integr Med"},{"key":"1048_CR47","doi-asserted-by":"crossref","unstructured":"Raaman N. Qualitative phytochemical screening. Phytochemical techniques. New India Publishing. 2006.","DOI":"10.59317\/9789390083404"},{"issue":"2","key":"1048_CR48","first-page":"067","volume":"3","author":"D Krishnaiah","year":"2009","unstructured":"Krishnaiah D, Devi T, Bono A, Sarbatly R. Studies on phytochemical constituents of six Malaysian medicinal plants. J Med Plant Res. 2009;3(2):067\u201372.","journal-title":"J Med Plant Res"},{"issue":"7","key":"1048_CR49","doi-asserted-by":"crossref","first-page":"685","DOI":"10.5897\/AJB2005.000-3127","volume":"4","author":"H Edeoga","year":"2005","unstructured":"Edeoga H, Okwu D, Mbaebie B. Phytochemical constituents of some Nigerian medicinal plants. Afr J Biotechnol. 2005;4(7):685\u20138.","journal-title":"Afr J Biotechnol"},{"issue":"4","key":"1048_CR50","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/S0306-3623(97)00335-2","volume":"30","author":"A Dogrul","year":"1998","unstructured":"Dogrul A, Yesilyurt O. Effects of intrathecally administered aminoglycoside antibiotics, calcium-channel blockers, nickel and calcium on acetic acid-induced writhing test in mice. General Pharmacol. 1998;30(4):613\u20136.","journal-title":"General Pharmacol"},{"key":"1048_CR51","first-page":"903","volume":"3","author":"F Subhan","year":"2010","unstructured":"Subhan F, Abbas M, Rauf K, Arfan M, Sewell RD, Ali G. The role of opioidergic mechanism in the activity of Bacopa monnieri extract against tonic and acute phasic pain modalities. Pharmacology Online. 2010;3:903\u201314.","journal-title":"Pharmacology Online"},{"issue":"1","key":"1048_CR52","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1007\/BF00432023","volume":"84","author":"J Simiand","year":"1984","unstructured":"Simiand J, Keane P, Morre M. The staircase test in mice: a simple and efficient procedure for primary screening of anxiolytic agents. Psychopharmacology (Berl). 1984;84(1):48\u201353.","journal-title":"Psychopharmacology (Berl)"},{"issue":"5","key":"1048_CR53","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1002\/ptr.2980","volume":"24","author":"F Subhan","year":"2010","unstructured":"Subhan F, Karim N, Gilani AH, Sewell RD. Terpenoid content of Valeriana wallichii extracts and antidepressant like response profiles. Phytother Res. 2010;24(5):686\u201391.","journal-title":"Phytother Res"},{"issue":"1","key":"1048_CR54","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S0304-3959(98)00239-5","volume":"80","author":"M John Field","year":"1999","unstructured":"John Field M, McCleary S, Hughes J, Singh L. Gabapentin and pregabalin, but not morphine and amitriptyline, block both static and dynamic components of mechanical allodynia induced by streptozocin in the rat. Pain. 1999;80(1):391\u20138.","journal-title":"Pain"},{"issue":"1","key":"1048_CR55","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0165-0270(94)90144-9","volume":"53","author":"S Chaplan","year":"1994","unstructured":"Chaplan S, Bach F, Pogrel J, Chung J, Yaksh T. Quantitative assessment of tactile allodynia in the rat paw. J Neurosci Methods. 1994;53(1):55\u201363.","journal-title":"J Neurosci Methods"},{"key":"1048_CR56","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1007\/s00210-015-1145-y","volume":"388","author":"G Ali","year":"2015","unstructured":"Ali G, Subhan F, Abbas M, Zeb J, Shahid M, Sewell RD. A streptozotocin-induced diabetic neuropathic pain model for static or dynamic mechanical allodynia and vulvodynia: validation using topical and systemic gabapentin. Naunyn Schmiedebergs Arch Pharmacol. 2015;388:1129\u201340.","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"issue":"1","key":"1048_CR57","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1471-2210-2-7","volume":"2","author":"H Hosseinzadeh","year":"2002","unstructured":"Hosseinzadeh H, Younesi HM. Antinociceptive and anti-inflammatory effects of Crocus sativus L. stigma and petal extracts in mice. BMC Pharmacol. 2002;2(1):7\u201314.","journal-title":"BMC Pharmacol"},{"issue":"2","key":"1048_CR58","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.jep.2005.05.039","volume":"102","author":"PR Verma","year":"2005","unstructured":"Verma PR, Joharapurkar AA, Chatpalliwar VA, Asnani AJ. Antinociceptive activity of alcoholic extract of Hemidesmus indicus R. Br. in mice. J Ethnopharmacol. 2005;102(2):298\u2013301.","journal-title":"J Ethnopharmacol"},{"issue":"7","key":"1048_CR59","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.fitote.2008.06.005","volume":"79","author":"MR Sulaiman","year":"2008","unstructured":"Sulaiman MR, Hussain M, Zakaria ZA, Somchit M, Moin S, Mohamad A, et al. Evaluation of the antinociceptive activity of Ficus deltoidea aqueous extract. Fitoterapia. 2008;79(7):557\u201361.","journal-title":"Fitoterapia"},{"issue":"4","key":"1048_CR60","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/S1734-1140(12)70877-0","volume":"64","author":"K Sa\u0142at","year":"2012","unstructured":"Sa\u0142at K, Wi\u0119ckowska A, Wi\u0119ckowski K, H\u00f6fner GC, Kami\u0144ski J, Wanner KT, et al. Synthesis and pharmacological properties of new GABA uptake inhibitors. Pharmacol Rep. 2012;64(4):817\u201333.","journal-title":"Pharmacol Rep"},{"key":"1048_CR61","first-page":"682","volume":"6","author":"GF Britto","year":"2012","unstructured":"Britto GF, Subash K, Rao NJ, Cheriyan BV, Kumar SV. A synergistic approach to evaluate the anti-nociceptive activity of a GABA agonist with opioids in albino mice. J Clin Diagn Res. 2012;6:682\u20137.","journal-title":"J Clin Diagn Res"},{"issue":"2","key":"1048_CR62","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1076\/phbi.41.2.87.14241","volume":"41","author":"K Dhawan","year":"2003","unstructured":"Dhawan K, Kumar S, Sharma A. Evaluation of central nervous system effects of Passiflora incarnata in experimental animals. Pharm Biol. 2003;41(2):87\u201391.","journal-title":"Pharm Biol"},{"issue":"1","key":"1048_CR63","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1111\/j.1399-6576.1997.tb04623.x","volume":"41","author":"T Yaksh","year":"1997","unstructured":"Yaksh T. Pharmacology and mechanisms of opioid analgesic activity. Acta Anaesthesiol Scand. 1997;41(1):94\u2013111.","journal-title":"Acta Anaesthesiol Scand"},{"key":"1048_CR64","doi-asserted-by":"crossref","unstructured":"McCarson KE, Enna S. GABA pharmacology: the search for analgesics. Neurochem Res. 2014;1\u201316.","DOI":"10.1007\/s11064-014-1254-x"},{"issue":"12","key":"1048_CR65","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1016\/j.phymed.2010.03.002","volume":"17","author":"S-M Elsas","year":"2010","unstructured":"Elsas S-M, Rossi D, Raber J, White G, Seeley C-A, Gregory W, et al. Passiflora incarnata L. (Passionflower) extracts elicit GABA currents in hippocampal neurons in vitro, and show anxiogenic and anticonvulsant effects in vivo, varying with extraction method. Phytomedicine. 2010;17(12):940\u20139.","journal-title":"Phytomedicine"},{"issue":"6","key":"1048_CR66","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1002\/ptr.3352","volume":"25","author":"K Appel","year":"2011","unstructured":"Appel K, Rose T, Fiebich B, Kammler T, Hoffmann C, Weiss G. Modulation of the \u03b3-aminobutyric acid (GABA) system by Passiflora incarnata L. Phytother Res. 2011;25(6):838\u201343.","journal-title":"Phytother Res"},{"issue":"1","key":"1048_CR67","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/ddr.430030102","volume":"3","author":"F DeFeudis","year":"1983","unstructured":"DeFeudis F. Central GABA\u2010ergic systems and analgesia. Drug Dev Res. 1983;3(1):1\u201315.","journal-title":"Drug Dev Res"},{"issue":"15","key":"1048_CR68","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1016\/j.lfs.2004.07.028","volume":"76","author":"DA Gries","year":"2005","unstructured":"Gries DA, Condouris GA, Shey Z, Houpt M. Anxiolytic-like action in mice treated with nitrous oxide and oral triazolam or diazepam. Life Sci. 2005;76(15):1667\u201374.","journal-title":"Life Sci"},{"issue":"03","key":"1048_CR69","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1055\/s-2006-960076","volume":"57","author":"A Rolland","year":"1991","unstructured":"Rolland A, Fleurentin J, Lanhers M-C, Younos C, Misslin R, Mortier F, et al. Behavioural effects of the American traditional plant Eschscholzia californica: Sedative and anxiolytic properties. Planta Med. 1991;57(03):212\u20136.","journal-title":"Planta Med"},{"issue":"6","key":"1048_CR70","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1002\/ptr.3332","volume":"25","author":"C Sampath","year":"2011","unstructured":"Sampath C, Holbik M, Krenn L, Butterweck V. Anxiolytic effects of fractions obtained from Passiflora incarnata L. in the elevated plus maze in mice. Phytother Res. 2011;25(6):789\u201395.","journal-title":"Phytother Res"},{"issue":"5","key":"1048_CR71","first-page":"333","volume":"75","author":"E Brown","year":"2007","unstructured":"Brown E, Hurd NS, McCall S, Ceremuga TE. Evaluation of the anxiolytic effects of chrysin, a Passiflora incarnata extract, in the laboratory rat. AANA J. 2007;75(5):333\u20137.","journal-title":"AANA J"},{"issue":"15","key":"1048_CR72","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1055\/s-0028-1088322","volume":"74","author":"O Grundmann","year":"2008","unstructured":"Grundmann O, Wang J, McGregor GP, Butterweck V. Anxiolytic activity of a phytochemically characterized Passiflora incarnata extract is mediated via the GABAergic system. Planta Med. 2008;74(15):1769\u201373.","journal-title":"Planta Med"},{"issue":"03","key":"1048_CR73","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1017\/S0140525X97261480","volume":"20","author":"Z Wiesenfeld-Hallin","year":"1997","unstructured":"Wiesenfeld-Hallin Z, Aldskogius H, Grant G, Hao J-X, H\u00f6kfelt T, Xu X-J. Central inhibitory dysfunctions: mechanisms and clinical implications. Behav Brain Sci. 1997;20(03):420\u20135.","journal-title":"Behav Brain Sci"},{"issue":"1","key":"1048_CR74","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0304-3959(96)03249-6","volume":"70","author":"J,L Hyun Hwang","year":"1997","unstructured":"Hyun Hwang J,L, Yaksh T. The effect of spinal GABA receptor agonists on tactile allodynia in a surgically-induced neuropathic pain model in the rat. Pain. 1997;70(1):15\u201322.","journal-title":"Pain"},{"issue":"2\u20103","key":"1048_CR75","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1002\/(SICI)1098-2299(199806\/07)44:2\/3<106::AID-DDR8>3.0.CO;2-Q","volume":"44","author":"WJ Giardina","year":"1998","unstructured":"Giardina WJ, Decker MW, Porsolt RD, Roux S, Collins SD, Kim DJ, et al. An evaluation of the GABA uptake blocker tiagabine in animal models of neuropathic and nociceptive pain. Drug Dev Res. 1998;44(2\u20103):106\u201313.","journal-title":"Drug Dev Res"},{"issue":"3","key":"1048_CR76","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1124\/jpet.104.081778","volume":"313","author":"MO Urban","year":"2005","unstructured":"Urban MO, Ren K, Park KT, Campbell B, Anker N, Stearns B, et al. Comparison of the antinociceptive profiles of gabapentin and 3-methylgabapentin in rat models of acute and persistent pain: Implications for mechanism of action. J Pharmacol Exp Ther. 2005;313(3):1209\u201316.","journal-title":"J Pharmacol Exp Ther"},{"issue":"23","key":"1048_CR77","doi-asserted-by":"crossref","first-page":"3013","DOI":"10.2174\/1381612054865055","volume":"11","author":"R Przewlocki","year":"2005","unstructured":"Przewlocki R, Przewlocka B. Opioids in neuropathic pain. Curr Pharm Des. 2005;11(23):3013\u201325.","journal-title":"Curr Pharm Des"},{"issue":"1","key":"1048_CR78","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/0304-3959(88)90198-4","volume":"33","author":"S Arn\u00e9r","year":"1988","unstructured":"Arn\u00e9r S, Meyerson BA. Lack of analgesic effect of opioids on neuropathic and idiopathic forms of pain. Pain. 1988;33(1):11\u201323.","journal-title":"Pain"},{"issue":"2","key":"1048_CR79","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.pain.2008.01.004","volume":"138","author":"Y Guan","year":"2008","unstructured":"Guan Y, Johanek LM, Hartke TV, Shim B, Tao Y-X, Ringkamp M, et al. Peripherally acting mu-opioid receptor agonist attenuates neuropathic pain in rats after L5 spinal nerve injury. Pain. 2008;138(2):318\u201329.","journal-title":"Pain"},{"issue":"8","key":"1048_CR80","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.ejpain.2005.10.007","volume":"10","author":"E Eisenberg","year":"2006","unstructured":"Eisenberg E, McNicol ED, Carr DB. Efficacy of mu\u2010opioid agonists in the treatment of evoked neuropathic pain: systematic review of randomized controlled trials. Eur J Pain. 2006;10(8):667.","journal-title":"Eur J Pain"},{"issue":"3","key":"1048_CR81","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/0304-3959(93)90224-D","volume":"53","author":"JA Desmeules","year":"1993","unstructured":"Desmeules JA, Kayser V, Guilbaud G. Selective opioid receptor agonists modulate mechanical allodynia in an animal model of neuropathic pain. Pain. 1993;53(3):277\u201385.","journal-title":"Pain"},{"issue":"1","key":"1048_CR82","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S1090-3801(99)90186-6","volume":"3","author":"C Felipe","year":"1999","unstructured":"Felipe C, Gonzalez GG, Gallar J, Belmonte C. Quantification and immunocytochemical characteristics of trigeminal ganglion neurons projecting to the cornea: effect of corneal wounding. Eur J Pain. 1999;3(1):31\u20139.","journal-title":"Eur J Pain"},{"issue":"7176","key":"1048_CR83","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/nature06493","volume":"451","author":"J Knabl","year":"2008","unstructured":"Knabl J, Witschi R, H\u00f6sl K, Reinold H, Zeilhofer UB, Ahmadi S, et al. Reversal of pathological pain through specific spinal GABAA receptor subtypes. Nature. 2008;451(7176):330\u20134.","journal-title":"Nature"},{"issue":"4","key":"1048_CR84","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1089\/neu.2009.1166","volume":"27","author":"JG Meisner","year":"2010","unstructured":"Meisner JG, Marsh AD, Marsh DR. Loss of GABAergic interneurons in laminae I\u2013III of the spinal cord dorsal horn contributes to reduced GABAergic tone and neuropathic pain after spinal cord injury. J Neurotrauma. 2010;27(4):729\u201337.","journal-title":"J Neurotrauma"},{"issue":"4","key":"1048_CR85","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/j.pain.2010.12.034","volume":"152","author":"J Yowtak","year":"2011","unstructured":"Yowtak J, Lee KY, Kim HY, Wang J, Kim HK, Chung K, et al. Reactive oxygen species contribute to neuropathic pain by reducing spinal GABA release. Pain. 2011;152(4):844\u201352.","journal-title":"Pain"},{"issue":"15","key":"1048_CR86","doi-asserted-by":"crossref","first-page":"6724","DOI":"10.1523\/JNEUROSCI.22-15-06724.2002","volume":"22","author":"KA Moore","year":"2002","unstructured":"Moore KA, Kohno T, Karchewski LA, Scholz J, Baba H, Woolf CJ. Partial peripheral nerve injury promotes a selective loss of GABAergic inhibition in the superficial dorsal horn of the spinal cord. J Neurosci. 2002;22(15):6724\u201331.","journal-title":"J Neurosci"},{"issue":"3","key":"1048_CR87","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1002\/jps.2600550302","volume":"55","author":"NR Farnsworth","year":"1966","unstructured":"Farnsworth NR. Biological and phytochemical screening of plants. J Pharm Sci. 1966;55(3):225\u201376.","journal-title":"J Pharm Sci"},{"issue":"6","key":"1048_CR88","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/S0367-326X(01)00306-9","volume":"72","author":"K Dhawan","year":"2001","unstructured":"Dhawan K, Kumar S, Sharma A. Comparative biological activity study on Passiflora incarnata and P. edulis. Fitoterapia. 2001;72(6):698\u2013702.","journal-title":"Fitoterapia"},{"issue":"1","key":"1048_CR89","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S0021-9673(97)00260-4","volume":"777","author":"A Raffaelli","year":"1997","unstructured":"Raffaelli A, Moneti G, Mercati V, Toja E. Mass spectrometric characterization of flavonoids in extracts from Passiflora incarnata. J Chromatogr A. 1997;777(1):223\u201331.","journal-title":"J Chromatogr A"},{"issue":"12","key":"1048_CR90","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1002\/ptr.1997","volume":"20","author":"M Coleta","year":"2006","unstructured":"Coleta M, Batista MT, Campos MG, Carvalho R, Cotrim MD, Lima TCM, et al. Neuropharmacological evaluation of the putative anxiolytic effects of Passiflora edulis Sims, its sub\u2010fractions and flavonoid constituents. Phytother Res. 2006;20(12):1067\u201373.","journal-title":"Phytother Res"},{"issue":"8","key":"1048_CR91","doi-asserted-by":"crossref","first-page":"967","DOI":"10.3181\/0902-RM-84","volume":"234","author":"LM Sena","year":"2009","unstructured":"Sena LM, Zucolotto SM, Reginatto FH, Schenkel EP, De Lima TCM. Neuropharmacological activity of the pericarp of Passiflora edulis flavicarpa degener: putative involvement of C-glycosylflavonoids. Exp Biol Med. 2009;234(8):967\u201375.","journal-title":"Exp Biol Med"},{"issue":"14","key":"1048_CR92","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1016\/j.phymed.2011.06.018","volume":"18","author":"M Herrera-Ruiz","year":"2011","unstructured":"Herrera-Ruiz M, Zamilpa A, Gonz\u00e1lez-Cortazar M, Reyes-Chilpa R, Le\u00f3n E, Garc\u00eda M, et al. Antidepressant effect and pharmacological evaluation of standardized extract of flavonoids from Byrsonima crassifolia. Phytomedicine. 2011;18(14):1255\u201361.","journal-title":"Phytomedicine"},{"issue":"2","key":"1048_CR93","first-page":"215","volume":"6","author":"K Dhawan","year":"2003","unstructured":"Dhawan K, Dhawan S, Chhabra S. Attenuation of benzodiazepine dependence in mice by a tri-substituted benzoflavone moiety of Passiflora incarnata Linneaus: a non-habit forming anxiolytic. J Pharm Pharm Sci. 2003;6(2):215\u201322.","journal-title":"J Pharm Pharm Sci"},{"issue":"2","key":"1048_CR94","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0378-8741(02)00086-7","volume":"81","author":"K Dhawan","year":"2002","unstructured":"Dhawan K, Kumar S, Sharma A. Suppression of alcohol-cessation-oriented hyper-anxiety by the benzoflavone moiety of Passiflora incarnata Linneaus in mice. J Ethnopharmacol. 2002;81(2):239\u201344.","journal-title":"J Ethnopharmacol"},{"key":"1048_CR95","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.neuropharm.2013.04.020","volume":"72","author":"J Higgs","year":"2013","unstructured":"Higgs J, Wasowski C, Loscalzo LM, Marder M. In vitro binding affinities of a series of flavonoids for \u03bc-opioid receptors. Antinociceptive effect of the synthetic flavonoid 3, 3-dibromoflavanone in mice. Neuropharmacology. 2013;72:9\u201319.","journal-title":"Neuropharmacology"},{"issue":"6","key":"1048_CR96","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1007\/s12272-001-1217-2","volume":"31","author":"A Willain Filho","year":"2008","unstructured":"Willain Filho A, Cechinel Filho V, Olinger L, de Souza MM. Quercetin: Further investigation of its antinociceptive properties and mechanisms of action. Arch Pharm Res. 2008;31(6):713\u201321.","journal-title":"Arch Pharm Res"},{"issue":"4","key":"1048_CR97","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/j.fitote.2012.01.010","volume":"83","author":"AD Kandhare","year":"2012","unstructured":"Kandhare AD, Raygude KS, Ghosh P, Ghule AE, Bodhankar SL. Neuroprotective effect of naringin by modulation of endogenous biomarkers in streptozotocin induced painful diabetic neuropathy. Fitoterapia. 2012;83(4):650\u20139.","journal-title":"Fitoterapia"},{"issue":"12","key":"1048_CR98","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1016\/j.bcp.2006.08.028","volume":"72","author":"FC Meotti","year":"2006","unstructured":"Meotti FC, Missau FC, Ferreira J, Pizzolatti MG, Mizuzaki C, Nogueira CW, et al. Anti-allodynic property of flavonoid myricitrin in models of persistent inflammatory and neuropathic pain in mice. Biochem Pharmacol. 2006;72(12):1707\u201313.","journal-title":"Biochem Pharmacol"},{"issue":"3","key":"1048_CR99","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.ejphar.2006.03.006","volume":"536","author":"S Sharma","year":"2006","unstructured":"Sharma S, Kulkarni SK, Agrewala JN, Chopra K. Curcumin attenuates thermal hyperalgesia in a diabetic mouse model of neuropathic pain. Eur J Pharmacol. 2006;536(3):256\u201361.","journal-title":"Eur J Pharmacol"},{"issue":"1","key":"1048_CR100","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/BF00568248","volume":"10","author":"N Gavasheli","year":"1974","unstructured":"Gavasheli N, Moniavo I, Eristavi L. Flavonoids from Passiflora incarnata. Chem Nat Compounds. 1974;10(1):99.","journal-title":"Chem Nat Compounds"},{"issue":"19","key":"1048_CR101","first-page":"1496","volume":"30","author":"C Feng","year":"2005","unstructured":"Feng C, Zhang L, Liu X. Progress in research of aldose reductase inhibitors in traditional medicinal herbs. Zhongguo Zhong Yao Za Zhi. 2005;30(19):1496\u2013500.","journal-title":"Zhongguo Zhong Yao Za Zhi"},{"issue":"3","key":"1048_CR102","doi-asserted-by":"crossref","first-page":"2877","DOI":"10.3390\/molecules19032877","volume":"19","author":"M Galuppo","year":"2014","unstructured":"Galuppo M, Giacoppo S, Bramanti P, Mazzon E. Use of natural compounds in the management of diabetic peripheral neuropathy. Molecules. 2014;19(3):2877\u201395.","journal-title":"Molecules"},{"issue":"6","key":"1048_CR103","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/S0278-5846(03)00160-X","volume":"27","author":"M Anjaneyulu","year":"2003","unstructured":"Anjaneyulu M, Chopra K. Quercetin, a bioflavonoid, attenuates thermal hyperalgesia in a mouse model of diabetic neuropathic pain. Prog Neuropsychopharmacol Biol Psychiatry. 2003;27(6):1001\u20135.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"1","key":"1048_CR104","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/S0022-3565(24)29334-4","volume":"299","author":"I Fedorova","year":"2001","unstructured":"Fedorova I, Hashimoto A, Fecik RA, Hedrick MP, Hanu\u0161 LO, Boger DL, et al. Behavioral evidence for the interaction of oleamide with multiple neurotransmitter systems. J Pharmacol Exp Ther. 2001;299(1):332\u201342.","journal-title":"J Pharmacol Exp Ther"},{"issue":"18","key":"1048_CR105","doi-asserted-by":"crossref","first-page":"4143","DOI":"10.1097\/00001756-200112210-00056","volume":"12","author":"AD Laposky","year":"2001","unstructured":"Laposky AD, Homanics GE, Basile A, Mendelson WB. Deletion of the GABAA receptor \u03b23 subunit eliminates the hypnotic actions of oleamide in mice. Neuroreport. 2001;12(18):4143\u20137.","journal-title":"Neuroreport"},{"issue":"6","key":"1048_CR106","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1213\/00000539-199806000-00031","volume":"86","author":"CS Yost","year":"1998","unstructured":"Yost CS, Hampson AJ, Leonoudakis D, Koblin DD, Bornheim LM, Gray AT. Oleamide potentiates benzodiazepine-sensitive gamma-aminobutyric acid receptor activity but does not alter minimum alveolar anesthetic concentration. Anesth Analg. 1998;86(6):1294\u2013300.","journal-title":"Anesth Analg"},{"issue":"2","key":"1048_CR107","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1038\/sj.bjp.0703051","volume":"129","author":"B Verdon","year":"2000","unstructured":"Verdon B, Zheng J, Nicholson RA, Ganelli CR, Lees G. Stereoselective modulatory actions of oleamide on GABAA receptors and voltage-gated Na\u2009+\u2009channels in vitro: a putative endogenous ligand for depressant drug sites in CNS. Br J Pharmacol. 2000;129(2):283\u201390.","journal-title":"Br J Pharmacol"},{"issue":"6","key":"1048_CR108","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.1046\/j.1471-4159.1999.0722370.x","volume":"72","author":"EA Thomas","year":"1999","unstructured":"Thomas EA, Cravatt BF, Sutcliffe JG. The endogenous lipid oleamide activates serotonin 5-HT7 neurons in mouse thalamus and hypothalamus. J Neurochem. 1999;72(6):2370\u20138.","journal-title":"J Neurochem"},{"issue":"8","key":"1048_CR109","doi-asserted-by":"crossref","first-page":"4102","DOI":"10.1073\/pnas.95.8.4102","volume":"95","author":"DL Boger","year":"1998","unstructured":"Boger DL, Patterson JE, Jin Q. Structural requirements for 5-HT2A and 5-HT1A serotonin receptor potentiation by the biologically active lipid oleamide. Proc Natl Acad Sci. 1998;95(8):4102\u20137.","journal-title":"Proc Natl Acad Sci"},{"issue":"9","key":"1048_CR110","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1017\/S1461145710000702","volume":"13","author":"E Soria-G\u00f3mez","year":"2010","unstructured":"Soria-G\u00f3mez E, M\u00e1rquez-Diosdado MI, Montes-Rodr\u00edguez CJ, Estrada-Gonz\u00e1lez V, Prosp\u00e9ro-Garc\u00eda O. Oleamide administered into the nucleus accumbens shell regulates feeding behaviour via CB1 and 5-HT2C receptors. Int J Neuropsychopharmacol. 2010;13(9):1247\u201354.","journal-title":"Int J Neuropsychopharmacol"},{"issue":"25","key":"1048_CR111","doi-asserted-by":"crossref","first-page":"14115","DOI":"10.1073\/pnas.94.25.14115","volume":"94","author":"EA Thomas","year":"1997","unstructured":"Thomas EA, Carson MJ, Neal MJ, Sutcliffe JG. Unique allosteric regulation of 5-hydroxytryptamine receptor-mediated signal transduction by oleamide. Proc Natl Acad Sci. 1997;94(25):14115\u20139.","journal-title":"Proc Natl Acad Sci"},{"issue":"1","key":"1048_CR112","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1097\/00000542-200101000-00022","volume":"94","author":"RA Nicholson","year":"2001","unstructured":"Nicholson RA, Zheng J, Ganellin CR, Verdon B, Lees G. Anesthetic-like interaction of the sleep-inducing lipid oleamide with voltage-gated sodium channels in mammalian brain. Anesthesiology. 2001;94(1):120\u20138.","journal-title":"Anesthesiology"},{"issue":"2","key":"1048_CR113","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1038\/sj.bjp.0705607","volume":"141","author":"JD Leggett","year":"2004","unstructured":"Leggett JD, Aspley S, Beckett S, D\u2019Antona A, Kendall D. Oleamide is a selective endogenous agonist of rat and human CB1 cannabinoid receptors. Br J Pharmacol. 2004;141(2):253\u201362.","journal-title":"Br J Pharmacol"},{"issue":"1","key":"1048_CR114","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0009-3084(02)00152-4","volume":"121","author":"JM Walker","year":"2002","unstructured":"Walker JM, Krey JF, Chu CJ, Huang SM. Endocannabinoids and related fatty acid derivatives in pain modulation. Chem Phys Lipids. 2002;121(1):159\u201372.","journal-title":"Chem Phys Lipids"},{"issue":"1","key":"1048_CR115","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.foodres.2012.12.044","volume":"51","author":"X Yu","year":"2013","unstructured":"Yu X, Zhao M, Liu F, Zeng S, Hu J. Identification of 2, 3-dihydro-3, 5-dihydroxy-6-methyl-4H-pyran-4-one as a strong antioxidant in glucose\u2013histidine Maillard reaction products. Food Res Int. 2013;51(1):397\u2013403.","journal-title":"Food Res Int"},{"issue":"3","key":"1048_CR116","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/s00217-011-1527-4","volume":"233","author":"L \u010cechovsk\u00e1","year":"2011","unstructured":"\u010cechovsk\u00e1 L, Cejpek K, Kone\u010dn\u00fd M, Vel\u00ed\u0161ek J. On the role of 2, 3-dihydro-3, 5-dihydroxy-6-methyl-(4H)-pyran-4-one in antioxidant capacity of prunes. Eur Food Res Technol. 2011;233(3):367\u201376.","journal-title":"Eur Food Res Technol"},{"issue":"2","key":"1048_CR117","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.mcn.2004.01.012","volume":"26","author":"J Rathenberg","year":"2004","unstructured":"Rathenberg J, Kittler JT, Moss SJ. Palmitoylation regulates the clustering and cell surface stability of GABA A receptors. Mol Cell Neurosci. 2004;26(2):251\u20137.","journal-title":"Mol Cell Neurosci"},{"issue":"5","key":"1048_CR118","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1200\/JCO.2003.05.139","volume":"21","author":"A Pace","year":"2003","unstructured":"Pace A, Savarese A, Picardo M, Maresca V, Pacetti U, Del Monte G, et al. Neuroprotective effect of vitamin E supplementation in patients treated with cisplatin chemotherapy. J Clin Oncol. 2003;21(5):927\u201331.","journal-title":"J Clin Oncol"},{"issue":"1","key":"1048_CR119","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1212\/01.WNL.0000148609.35718.7D","volume":"64","author":"A Argyriou","year":"2005","unstructured":"Argyriou A, Chroni E, Koutras A, Ellul J, Papapetropoulos S, Katsoulas G, et al. Vitamin E for prophylaxis against chemotherapy-induced neuropathy: a randomized controlled trial. Neurology. 2005;64(1):26\u201331.","journal-title":"Neurology"},{"issue":"11","key":"1048_CR120","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1007\/s001250100001","volume":"44","author":"N Cameron","year":"2001","unstructured":"Cameron N, Eaton S, Cotter M, Tesfaye S. Vascular factors and metabolic interactions in the pathogenesis of diabetic neuropathy. Diabetologia. 2001;44(11):1973\u201388.","journal-title":"Diabetologia"},{"key":"1048_CR121","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0074-7742(02)50078-7","volume":"50","author":"NA Calcutt","year":"2002","unstructured":"Calcutt NA. Potential mechanisms of neuropathic pain in diabetes. Int Rev Neurobiol. 2002;50:205\u201328.","journal-title":"Int Rev Neurobiol"},{"issue":"4","key":"1048_CR122","doi-asserted-by":"crossref","first-page":"956","DOI":"10.2337\/diacare.28.4.956","volume":"28","author":"AJ Boulton","year":"2005","unstructured":"Boulton AJ, Vinik AI, Arezzo JC, Bril V, Feldman EL, Freeman R, et al. Diabetic neuropathies a statement by the American Diabetes Association. Diabetes Care. 2005;28(4):956\u201362.","journal-title":"Diabetes Care"},{"issue":"5","key":"1048_CR123","doi-asserted-by":"crossref","first-page":"787","DOI":"10.4103\/2230-8210.117193","volume":"17","author":"B Kalra","year":"2013","unstructured":"Kalra B, Kalra S, Bajaj S. Vulvodynia: an unrecognized diabetic neuropathic syndrome. Indian J Endocrinol Metab. 2013;17(5):787.","journal-title":"Indian J Endocrinol Metab"},{"issue":"1","key":"1048_CR124","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1111\/j.1751-486X.2009.01373.x","volume":"13","author":"J Kingdon","year":"2009","unstructured":"Kingdon J. Vulvodynia. Nurs Womens Health. 2009;13(1):48\u201358.","journal-title":"Nurs Womens Health"},{"issue":"1","key":"1048_CR125","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1097\/00128360-200501000-00009","volume":"9","author":"HK Haefner","year":"2005","unstructured":"Haefner HK, Collins ME, Davis GD, Edwards L, Foster DC, Hartmann EDH, et al. The vulvodynia guideline. J Low Genit Tract Dis. 2005;9(1):40\u201351.","journal-title":"J Low Genit Tract Dis"}],"container-title":["BMC Complementary and Alternative Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12906-016-1048-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T13:59:28Z","timestamp":1748786368000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccomplementalternmed.biomedcentral.com\/articles\/10.1186\/s12906-016-1048-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2,24]]},"references-count":125,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["1048"],"URL":"https:\/\/doi.org\/10.1186\/s12906-016-1048-6","relation":{},"ISSN":["1472-6882"],"issn-type":[{"value":"1472-6882","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,2,24]]},"article-number":"77"}}